Dr. Mary Lynn Crow to be Featured on CUTV News Radio

FORT WORTH, TEXAS, UNITED STATES, January 11, 2018 /EINPresswire.com/ — Each of us finds ourselves somewhere on the life script. Some life stages are more difficult to find purpose and meaning and to overcome challenges than others.

According to licensed clinical psychologist and educator Dr. Mary Lynn Crow, the crises that typically occur in midlife begin much earlier than midlife, in adolescence.

“The first thing that helps is when people understand that there's some structure to the life script and you're not alone,” says Dr. Crow. “We go through transitions from one life stage to another. We have the research, we have the theoretical formations. We can predict. We're not just flying blind. Here's some structure. Now we can support you to apply it to what you're dealing with so that you can move forward.”

Dr. Crow specializes in helping people successfully address and master the challenges in every phase of life

“I keep coming back to finding meaning and purpose,” says Dr. Crow. “There are things that we can do besides counseling or therapy. We can build stable relationships. We can find something that is meaningful, whether it's a faith, a belief, whatever, so that you can hook into something to hang onto. You can build relationships that are built on unconditional love, not just attraction. Finding meaning and purpose as you move through these transitions is the key to living a healthy life in all facets.”

In addition to her work as a clinical psychologist, Dr. Crow also serves as a professor of developmental and educational psychology in the University of Texas system. Dr. Crow got her start in education as a teacher. Listeners may remember her as the kindergarten teacher on the old television program Romper Room. Romper Room International Television Kindergarten, featured an actual kindergarten live on air, with real lesson plans for real children.

“Romper Room was unlike any other children's shows of its day,” recalls Dr. Crow. “It was the first integrated show to actually bring on children of color, which had not been done before. I had live animals get loose. I learned a lot about control of time, control of self, and control in general. But I decided to go into higher education, which has now been my life for 48 years.”

CUTV News Radio will feature Dr. Mary Lynn Crow in an interview with Jim Masters on January 15th at 2pm EST and with Doug Llewelyn on January 22nd at 2pm EST.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Dr. Mary Lynn Crow, visit http://www.drmarylynncrow.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Smart Cannabis Corp. Gets Green Light to Publish its SMARTAPP Agriculture Automation App in Apple App Store

SMART Cannabis

SMART CANNABIS CORP (OTCMKTS:SCNA)

SACRAMENTO, CA, USA, January 11, 2018 /EINPresswire.com/ — Smart Cannabis Corp., (OTC PINK: SCNA), announced today that its SMARTAPP for Apple iPhone and iPad is now available for download on their app store. The Next Generation Farming SMARTAPP was developed exclusively by Smart Cannabis Corp. to provide complete remote management for their Smart by Design line of automated greenhouses as well as to offer a stable software platform for other companies to license and build upon.

The SMARTAPP, known as NextGen Farm in the Apple App Store, is immediately available for download, free of charge, and includes demonstration mode – available by logging into the user and password as “demo”. Prospective clients can get a sense of controlling a live automated greenhouse environment similar to the interface and control system used by active clients who control their greenhouse system functions remotely. Enabling their clients to grow more efficiently with this app will result in a greater return on investment, making Next Generation Farming an essential all-around agritech solution for farmers.

The company will sell the SMARTAPP to existing and new client installations on a subscription basis and already has sales commitments for approximately fifteen SMARTAPP automation systems which it plans to install over the next 45 days.

Recently, the company entered a multifaceted joint venture with Singlepoint Inc. (OTC:SING) According to Smart Cannabis Vice President Don Smith, “In addition to the advanced automation control of greenhouse ecosystems, one of the goals with Singlepoint is to program in data collection and basic bitcoin blockchain transaction technology to allow cultivators to extend their control capabilities to include transactions within our SMARTAPP.”

Smith added, “We are also pursuing conversations with a number of agriculture companies to white label/OEM the SMARTAPP for commercial and consumer gardening applications that would benefit from mobile yet robust automation and control systems. Whether you have a backyard greenhouse, or a commercial food cultivation business, we believe our SMARTAPP can fill a product niche somewhere in that control spectrum”. According to Agrilyst, the marketplace for agriculture remote control systems is expected to generate over $21 billion annually in the U.S., as data is critical in helping cultivators reduce costs and refine their systems to increase productivity based upon the collection of historical data, and real time monitoring and control.

For partnership opportunities or inquiries, email: don@nextgen.farm.

About Smart Cannabis
Smart Cannabis Corp., (OTC PINK: SCNA) is a public equity corporation focused on the advanced agriculture and cannabis industries with plans to grow through acquisition, strategic alliances, and proprietary intellectual property. The company’s wholly owned subsidiary Next Generation Farming Inc. provides turnkey commercial SMART greenhouse and automation systems that improve yields and decrease water consumption for cultivators of organic food and cannabis crops. The company's websites are: http://smartcannabis.com http://nextgen.farm.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company's public announcements.

DON SMITH
SMART CANNABIS CORP
424-732-7646
email us here


Source: EIN Presswire

Global Foot and Mouth Disease (FMD) Vaccines Market 2018 Size, Trends, Sales, Supply, Demand, Analysis, Forecast to 2022

WiseGuyReports.com adds “Foot and Mouth Disease (FMD) Vaccines Market 2018 Global Analysis Research Report Forecasting to 2025”reports to its database.

PUNE, INDIA, January 11, 2018 /EINPresswire.com/ — Foot and Mouth Disease (FMD) Vaccines Market:

Executive Summary

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2013 to 2025 (forecast), covering

North America
Europe
China
Japan
Southeast Asia
India

Global Foot and Mouth Disease (FMD) Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

MSD Animal Health
Bayer HealthCare
Sanofi(Merial)
Brilliant Bio Pharma
Agrovet
Inova Biotecnologia Saúde Animal Ltda.
IIL
MEVAC
BVI
VETAL
VSVRI
Biog nesis
VECOL
Limor de Colombia
RVSRI
Cavet Bio
Shen Lian
PVI
CAHIC
Tecon Group
Jinyu Group
China Animal Healthcare

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

A-Type
O-Type
C-Type
SAT-1 Type
SAT-2 Type
SAT-3 Type
Asia-1 Type

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Pig
Cattle
Sheep
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2765078-global-foot-and-mouth-disease-fmd-vaccines-market-research-report-2018

Table of content:

Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2018 
1 Foot and Mouth Disease (FMD) Vaccines Market Overview 
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines 
1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type (Product Category) 
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Foot and Mouth Disease (FMD) Vaccines Production Market Share by Type (Product Category) in 2017 
1.2.3 A-Type 
1.2.4 O-Type 
1.2.5 C-Type 
1.2.6 SAT-1 Type 
1.2.7 SAT-2 Type 
1.2.8 SAT-3 Type 
1.2.9 Asia-1 Type 
1.3 Global Foot and Mouth Disease (FMD) Vaccines Segment by Application 
1.3.1 Foot and Mouth Disease (FMD) Vaccines Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Pig 
1.3.3 Cattle 
1.3.4 Sheep 
1.3.5 Others 
1.4 Global Foot and Mouth Disease (FMD) Vaccines Market by Region (2013-2025) 
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Foot and Mouth Disease (FMD) Vaccines (2013-2025) 
1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue Status and Outlook (2013-2025) 
1.5.2 Global Foot and Mouth Disease (FMD) Vaccines Capacity, Production Status and Outlook (2013-2025)

2 Global Foot and Mouth Disease (FMD) Vaccines Market Competition by Manufacturers 
2.1 Global Foot and Mouth Disease (FMD) Vaccines Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Foot and Mouth Disease (FMD) Vaccines Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Foot and Mouth Disease (FMD) Vaccines Production and Share by Manufacturers (2013-2018) 
2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation and Trends 
2.5.1 Foot and Mouth Disease (FMD) Vaccines Market Concentration Rate 
2.5.2 Foot and Mouth Disease (FMD) Vaccines Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

3 Global Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Foot and Mouth Disease (FMD) Vaccines Capacity and Market Share by Region (2013-2018)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Production and Market Share by Region (2013-2018)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Foot and Mouth Disease (FMD) Vaccines Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Foot and Mouth Disease (FMD) Vaccines Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption by Region (2013-2018)
4.2 North America Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)
4.3 Europe Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)
4.4 China Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)
4.5 Japan Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)
4.7 India Foot and Mouth Disease (FMD) Vaccines Production, Consumption, Export, Import (2013-2018)

5 Global Foot and Mouth Disease (FMD) Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Foot and Mouth Disease (FMD) Vaccines Production and Market Share by Type (2013-2018)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share by Type (2013-2018)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2013-2018)
5.4 Global Foot and Mouth Disease (FMD) Vaccines Production Growth by Type (2013-2018)

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/2765078-global-foot-and-mouth-disease-fmd-vaccines-market-research-report-2018

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Hyperglycemia Drugs and Companies Pipeline Review H2 2018

Hyperglycemia Therapeutic and Disease Pipeline Review H2

PUNE, INDIA, January 11, 2018 /EINPresswire.com/ — Summary
Hyperglycemia is a condition that occurs when blood glucose levels get too high. Several factors can contribute to hyperglycemia, including food and physical activity choices, illness, non-diabetes medications, or not taking enough glucose-lowering medication. Symptoms include frequent urination, blurred vision, fatigue headache, nausea and vomiting, dry mouth, coma and confusion. Treatment includes anti-hyperglycemic therapy and insulin therapy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2740068-hyperglycemia-pipeline-review-h2-2017

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Hyperglycemia – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Hyperglycemia (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hyperglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Preclinical stages are 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 5 and 1 molecules, respectively.

Hyperglycemia (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Hyperglycemia (Metabolic Disorders).
– The pipeline guide reviews pipeline therapeutics for Hyperglycemia (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Hyperglycemia (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Hyperglycemia (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Hyperglycemia (Metabolic Disorders)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Hyperglycemia (Metabolic Disorders).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Hyperglycemia (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
List of Tables
List of Figures
Introduction
Hyperglycemia – Overview
Hyperglycemia – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperglycemia – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2740068-hyperglycemia-pipeline-review-h2-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Wearable Fitness Tracker Market 2018:Global Key Players,Trends,Industry Size,Segmentation,Opportunities Forecast To 2025

Wiseguyreports.Com Adds “Wearable Fitness Tracker –Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025”

PUNE, MAHARASHTRA, INDIA, January 11, 2018 /EINPresswire.com/ — Wearable Fitness Tracker Market 2018

Description:

In this report, the global Wearable Fitness Tracker market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Wearable Fitness Tracker in these regions, from 2013 to 2025 (forecast), covering
United States
EU
China
Japan
South Korea
Taiwan
Global Wearable Fitness Tracker market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Apple Inc.
Fitbit
Samsung
Garmin
Suunto
Casio
Polar
Xiaomi
Nokia

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/2758651-global-wearable-fitness-tracker-market-research-report-2018

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Bands
Watches
Leg Straps
Smart Garments
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Running
Biking
Climbing
Cardio Training
Others

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/2758651-global-wearable-fitness-tracker-market-research-report-2018

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents:

Global Wearable Fitness Tracker Market Research Report 2018
1 Wearable Fitness Tracker Market Overview
1.1 Product Overview and Scope of Wearable Fitness Tracker
1.2 Wearable Fitness Tracker Segment by Type (Product Category)
1.2.1 Global Wearable Fitness Tracker Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Wearable Fitness Tracker Production Market Share by Type (Product Category) in 2017
1.2.3 Bands
1.2.4 Watches
1.2.5 Leg Straps
1.2.6 Smart Garments
1.3 Global Wearable Fitness Tracker Segment by Application
1.3.1 Wearable Fitness Tracker Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Running
1.3.3 Biking
1.3.4 Climbing
1.3.5 Cardio Training
1.3.6 Others
1.4 Global Wearable Fitness Tracker Market by Region (2013-2025)
1.4.1 Global Wearable Fitness Tracker Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 United States Status and Prospect (2013-2025)
1.4.3 EU Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 South Korea Status and Prospect (2013-2025)
1.4.7 Taiwan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Wearable Fitness Tracker (2013-2025)
1.5.1 Global Wearable Fitness Tracker Revenue Status and Outlook (2013-2025)
1.5.2 Global Wearable Fitness Tracker Capacity, Production Status and Outlook (2013-2025)

2 Global Wearable Fitness Tracker Market Competition by Manufacturers
2.1 Global Wearable Fitness Tracker Capacity, Production and Share by Manufacturers(2013-2018)
2.1.1 Global Wearable Fitness Tracker Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Wearable Fitness Tracker Production and Share by Manufacturers (2013-2018)
2.2 Global Wearable Fitness Tracker Revenue and Share by Manufacturers (2013-2018)
2.3 Global Wearable Fitness Tracker Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Wearable Fitness Tracker Manufacturing Base Distribution, Sales Area and Product Type
2.5 Wearable Fitness Tracker Market Competitive Situation and Trends
2.5.1 Wearable Fitness Tracker Market Concentration Rate
2.5.2 Wearable Fitness Tracker Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

……..

7 Global Wearable Fitness Tracker Manufacturers Profiles/Analysis
7.1 Apple Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Wearable Fitness Tracker Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Apple Inc. Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Fitbit
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Wearable Fitness Tracker Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Fitbit Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Samsung
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Wearable Fitness Tracker Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Samsung Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Garmin
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Wearable Fitness Tracker Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Garmin Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Suunto
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Wearable Fitness Tracker Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Suunto Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Casio
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Wearable Fitness Tracker Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Casio Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Polar
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Wearable Fitness Tracker Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Polar Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Xiaomi
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Wearable Fitness Tracker Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Xiaomi Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Nokia
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Wearable Fitness Tracker Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Nokia Wearable Fitness Tracker Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview

Continued…..

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2758651

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Illinois Corporate Whistleblower Center Now Urges a Nursing Home Manager to Call About Rewards If Their Facility Is Short on Staff But billing Medicare As If They Are Fully Staffed

We are urging a staff member or manager at a nursing home anywhere in the Illinois to call us anytime at 866-714-6466 if Medicare is being overbilled for insufficient staff to care for their patients”

— Illinois Corporate Whistleblower Center

WASHINGTON, DC, USA, January 11, 2018 /EINPresswire.com/ — The Illinois Corporate Whistleblower Center says, "We are urging a staff member or manager at a nursing home anywhere in the Illinois to call us anytime at 866-714-6466 if Medicare is being overbilled for insufficient staff to care for their patients. This practice is called short-staffing and it happens in nursing homes in every state nationwide-including Illinois. Frequently nursing homes involved in short staffing also bill Medicare for medical procedures that never took place. If you have proof your employer-nursing home is significantly involved in these types of practices-there can significant rewards for this type of information as we would like to discuss- anytime." http://Illinois.CorporateWhistleblowerCenter.Com

On November 16th, 2017 the Department of Justice announced a $1,250,000 settlement from the operator of a nursing home in Mississippi based nursing home for providing effectively worthless services to residents. While the whistleblower reward has not yet been announced it is expected to be around $150,000.

The Illinois Corporate Whistleblower Center intends to ramp up their efforts to assist legitimate healthcare whistleblower's package their information in the hopes of increasing their potential whistleblower reward-with a focus on the following types of practices:

* Short staffed nursing homes in Illinois that are billing Medicare as if they are fully staffed.

* Hospice providers in Illinois that are billing Medicare for end of life medical treatment for people who are not dying.

* Drug company representatives in Illinois that are bribing medical doctors with the intent—the physician will over prescribe pharmaceutical products.

* Hospitals in Illinois that are admitting Medicare patients through their ER for expensive medical testing that should have never happened.

* Blood testing companies or imaging centers in Illinois that are paying off physicians for unwarranted expensive medical tests.

According to the Illinois Corporate Whistleblower Center, "We want the potential whistleblowers who call us to understand their information could result in a significant whistleblower reward-provided it is well documented, and the wrongdoing is easy to prove. If a MD or healthcare worker in Illinois knows of a multimillion dollar scheme to overbill Medicare please call us anytime at 866-714-6466 about what the reward potential could be for their information. Please don't sit on a potentially winning lotto ticket without ever know what it might have been worth." http://Illinois.CorporateWhistleblowerCenter.Com

Simple rules for a whistleblower from the Illinois Corporate Whistleblower Center: Do not go to the government first if you are a potential whistleblower with substantial proof of wrongdoing. The Illinois Corporate Whistleblower Center says, “Major whistleblowers frequently go to the government thinking they will help. It’s a huge mistake. Do not go to the news media with your whistleblower information. Public revelation of a whistleblower’s information could destroy any prospect for a reward. Do not try to force a company/employer or individual to come clean about significant Medicare fraud, overbilling the federal government for services never rendered, multimillion dollar state or federal tax evasion, or an Illinois based company falsely claiming to be a minority owned business to get preferential treatment on federal or state projects. Come to us first, tell us what type of information you have, and if we think it’s sufficient, we will help you with a focus on you getting rewarded.”

Unlike any group in the US the Corporate Whistleblower Center can assist a potential whistleblower with packaging or building out their information to potentially increase the reward potential. They will also provide the whistleblower with access to some of the most skilled whistleblower attorneys in the nation. For more information a possible whistleblower with substantial proof of wrongdoing in Illinois can contact the Corporate Whistleblower Center at 866-714-6466 or contact them via their website at http://Illinois.CorporateWhistleBlower.Com

For attribution please refer to the November 2017 United States Department of Justice press release regarding this matter. https://www.justice.gov/opa/pr/mississippi-skilled-nursing-facility-related-companies-and-executives-agree-pay-125-million

Thomas Martin
Illinois Corporate Whistleblower Center
866-714-6466
email us here


Source: EIN Presswire

Legal Marijuana – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

Legal Marijuana Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, January 11, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Legal Marijuana Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Legal Marijuana Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Legal Marijuana Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Marijuana is one of the most abused drugs in the world. And this report studies the Legal Marijuana. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Legal Marijuana market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
Medicine Man
Canopy Growth
Aphria
Aurora Cannabis Inc.
mCig Inc

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2699039-2015-2023-world-legal-marijuana-market-research-report-by-product

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Indoor
Indoor
Greenhouse

By End-User / Application
Recreational
Medical

At any Query @ https://www.wiseguyreports.com/enquiry/2699039-2015-2023-world-legal-marijuana-market-research-report-by-product

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Medicine Man
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Canopy Growth
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Aphria
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Aurora Cannabis Inc.
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 mCig Inc
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2699039

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Vitamin – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

Vitamin Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, January 11, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Vitamin Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Vitamin Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Vitamin Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Vitamin is a huge family, now known as vitamins have a few kinds, can divide roughly for fat-soluble and water-soluble two categories. Vitamin includes Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E and Vitamin K.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Vitamin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
DSM
Lonza
CSPC Pharmaceutical Group
BASF
Zhejiang Medicine
Shandong Luwei Pharmaceutical
Northeast Pharmaceutical
North China Pharmaceutical
NHU
Jubilant Life Sciences
Vertellus
Brother Enterprises
Adisseo
Zhejiang Garden Biochemical
Kingdomway

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2699312-2015-2023-world-vitamin-market-research-report-by-product-type

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Vitamin A
Vitamin B3
Vitamin B5
Vitamin D3
Vitamin E
Vitamin C
Others

By End-User / Application
Feed Additives
Pharmaceuticals and Cosmetics
Food and Beverage

At any Query @ https://www.wiseguyreports.com/enquiry/2699312-2015-2023-world-vitamin-market-research-report-by-product-type

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 DSM
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Lonza
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 CSPC Pharmaceutical Group
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 BASF
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Zhejiang Medicine
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Shandong Luwei Pharmaceutical
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Northeast Pharmaceutical
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 North China Pharmaceutical
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 NHU
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Jubilant Life Sciences
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Vertellus
12.12 Brother Enterprises
12.13 Adisseo
12.14 Zhejiang Garden Biochemical
12.15 Kingdomway

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2699312

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Medical Textiles – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

Medical Textiles Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, January 11, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Medical Textiles Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Medical Textiles Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Textiles Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Medical Textiles are used in hygiene, health and personal care, as well as in surgical applications. These products include: wipes, baby and adult diapers, adult sanitary and incontinence products, as well as, medical and surgical products, such as operating gowns, operating drapes, sterilization packs, dressings, sutures and orthopedic pads.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Medical Textiles market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
Medtronic (Covidien)
Johnson & Johnson
3M
BSN medical
Smith & Nephew
Molnlycke
Medline
Dupont
Cardinal Health
B. Braun
Allmed Medical
Ahlstrom
Winner Medical
Lohmann & Rauscher
JianErKang
Hakuzo
KOB
TWE Group
Zhende Medical
Vilene
Medpride
Techtex

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2628032-2015-2023-world-medical-textiles-market-research-report-by-product-type

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Non-woven Fabric
Woven Fabric
Knitted Fabrics

By End-User / Application
Implantable Goods
Non-implantable Goods
Healthcare & Hygiene Products
Others

At any Query @ https://www.wiseguyreports.com/enquiry/2628032-2015-2023-world-medical-textiles-market-research-report-by-product-type

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Medtronic (Covidien)
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Johnson & Johnson
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 3M
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 BSN medical
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Smith & Nephew
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Molnlycke
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Medline
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Dupont
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Cardinal Health
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 B. Braun
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Allmed Medical
12.12 Ahlstrom
12.13 Winner Medical
12.14 Lohmann & Rauscher
12.15 JianErKang
12.16 Hakuzo
12.17 KOB
12.18 TWE Group
12.19 Zhende Medical
12.20 Vilene
12.21 Medpride
12.22 Techtex

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2628032

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Insulin Delivery Devices Market 2018 To Reach Valued At $ 11.54 Billion And Grow At A 9.10% Cagr Forecast To 2025

Wiseguyreports.Com Adds “Insulin Delivery Devices –Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025”

PUNE, MAHARASHTRA, INDIA, January 11, 2018 /EINPresswire.com/ — Insulin Delivery Devices Market 2018

Description:

Global Insulin Delivery Devices valued approximately USD 11.54 Billion in 2016 is anticipated to grow with healthy growth rate of more than 9.10% over the forecast period 2017-2025. The Key drivers in the market include Government support in specific countries, favorable reimbursement technological advancements in insulin delivery devices, and rising diabetic population.

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Product Type:
§ Insulin syringes
§ Insulin pens
§ Insulin pumps
§ Insulin injectors

End-Use:
§ Hospital
§ Homecare
§ Others
Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
§ Asia Pacific
o China
o India
o Japan
§ Latin America
o Brazil
o Mexico
§ Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/2742074-global-insulin-delivery-devices-market-size-study-by-type-insulin

Some of the key manufacturers involved in the market are Novo Nordisk A/S, Sanofi, Eli Lilly and Company Biocon Ltd. Wockhardt Ltd and Medtronic. The companies are spending a lot on their research and development programs to keep up with the dynamically changing technologies in the market. Acquisitions and effective mergers are one of the expansion strategies taken by the key manufacturers.

Target Audience of the Insulin Delivery Devices Market Study

§ Key Consulting Companies & Advisors
§ Large, medium-sized, and small enterprises
§ Venture capitalists
§ Value-Added Resellers (VARs)
§ Third-party knowledge providers
§ Investment bankers
§ Investors
Please note that owing to the criticality of the Insulin Delivery Devices market and rapidly changing market attributes, we are in the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in order to cater to the most recent updates.

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/2742074-global-insulin-delivery-devices-market-size-study-by-type-insulin

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents:

Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption

Chapter 2. Global Insulin Delivery Devices Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation

Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4. Global Insulin Delivery Devices Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

……..

Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novo Nordisk A/S
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Sanofi
8.3.3. Eli Lilly and Company
8.3.4. Biocon Ltd.
8.3.5. Abbott Laboratories .
8.3.6. Wockhardt Ltd..
8.3.7. Becton, Dickinson and Company.
8.3.8. F. Hoffmann-La Roche, Ltd.
8.3.9. Tandem Diabetes Care, Inc.
8.3.10. Insulet Corporation.

Continued…..

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2742074

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire